

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.30367582 |
| 2 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.02289165 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 3.94158125 |
| 4 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.57418084 |
| 5 | regulation of chronic inflammatory response (GO:0002676) | 3.51676526 |
| 6 | positive regulation of defense response to virus by host (GO:0002230) | 3.47708556 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.44538084 |
| 8 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.33957330 |
| 9 | natural killer cell mediated immunity (GO:0002228) | 3.30854365 |
| 10 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.30854365 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.26943661 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 3.24926037 |
| 13 | kynurenine metabolic process (GO:0070189) | 3.23596594 |
| 14 | type I interferon signaling pathway (GO:0060337) | 3.22438478 |
| 15 | cellular response to type I interferon (GO:0071357) | 3.22438478 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 3.21647884 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.21465317 |
| 18 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.21053886 |
| 19 | response to type I interferon (GO:0034340) | 3.18147288 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 3.15476297 |
| 21 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14843923 |
| 22 | regulation of memory T cell differentiation (GO:0043380) | 3.11793400 |
| 23 | T-helper 1 type immune response (GO:0042088) | 3.04281580 |
| 24 | negative regulation of viral genome replication (GO:0045071) | 3.03945788 |
| 25 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.02856419 |
| 26 | B cell mediated immunity (GO:0019724) | 3.01586005 |
| 27 | regulation of mononuclear cell migration (GO:0071675) | 2.99655359 |
| 28 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.98745413 |
| 29 | sequestering of actin monomers (GO:0042989) | 2.95271625 |
| 30 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92284905 |
| 31 | positive regulation of interleukin-17 production (GO:0032740) | 2.90455751 |
| 32 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.90360850 |
| 33 | ribosome assembly (GO:0042255) | 2.89720130 |
| 34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.89713772 |
| 35 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.87919456 |
| 36 | tryptophan catabolic process (GO:0006569) | 2.86607664 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 2.86607664 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 2.86607664 |
| 39 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.85887258 |
| 40 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.83992469 |
| 41 | response to peptidoglycan (GO:0032494) | 2.83290488 |
| 42 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.83195809 |
| 43 | ribosomal large subunit biogenesis (GO:0042273) | 2.81583938 |
| 44 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.80098777 |
| 45 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.76938805 |
| 46 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.76938805 |
| 47 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.75904339 |
| 48 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.75660325 |
| 49 | neutrophil activation (GO:0042119) | 2.74982488 |
| 50 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.74542312 |
| 51 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.74471271 |
| 52 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.74471271 |
| 53 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.74471271 |
| 54 | maturation of SSU-rRNA (GO:0030490) | 2.73702001 |
| 55 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.72659744 |
| 56 | regulation of metalloenzyme activity (GO:0048552) | 2.72242117 |
| 57 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.72095989 |
| 58 | positive regulation of interferon-alpha production (GO:0032727) | 2.70486413 |
| 59 | platelet dense granule organization (GO:0060155) | 2.66888471 |
| 60 | negative regulation of monooxygenase activity (GO:0032769) | 2.66816968 |
| 61 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.64445040 |
| 62 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.64445040 |
| 63 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.64345113 |
| 64 | granulocyte activation (GO:0036230) | 2.63743737 |
| 65 | respiratory burst (GO:0045730) | 2.61818796 |
| 66 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.61790172 |
| 67 | response to interferon-beta (GO:0035456) | 2.60997276 |
| 68 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.60497825 |
| 69 | regulation of interleukin-1 secretion (GO:0050704) | 2.60032621 |
| 70 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59978521 |
| 71 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59036855 |
| 72 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.58833976 |
| 73 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.57951907 |
| 74 | regulation of chemokine biosynthetic process (GO:0045073) | 2.57777274 |
| 75 | negative regulation of ligase activity (GO:0051352) | 2.57163899 |
| 76 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.57163899 |
| 77 | positive regulation of natural killer cell activation (GO:0032816) | 2.56803495 |
| 78 | wound healing, spreading of epidermal cells (GO:0035313) | 2.56637426 |
| 79 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.56589734 |
| 80 | regulation of podosome assembly (GO:0071801) | 2.56086372 |
| 81 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.55255427 |
| 82 | cellular response to zinc ion (GO:0071294) | 2.54712655 |
| 83 | regulation of interleukin-12 production (GO:0032655) | 2.54142817 |
| 84 | telomere maintenance via recombination (GO:0000722) | 2.54081627 |
| 85 | regulation of interferon-alpha production (GO:0032647) | 2.53860775 |
| 86 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.53327401 |
| 87 | positive regulation of heat generation (GO:0031652) | 2.53287218 |
| 88 | cellular response to interferon-beta (GO:0035458) | 2.53146091 |
| 89 | translational termination (GO:0006415) | 2.51659422 |
| 90 | regulation of defense response to virus by host (GO:0050691) | 2.50438481 |
| 91 | leukocyte mediated cytotoxicity (GO:0001909) | 2.49744126 |
| 92 | defense response to protozoan (GO:0042832) | 2.49469836 |
| 93 | response to interferon-alpha (GO:0035455) | 2.49068999 |
| 94 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.47870659 |
| 95 | DNA replication initiation (GO:0006270) | 2.47426334 |
| 96 | viral transcription (GO:0019083) | 2.47186935 |
| 97 | cellular response to interferon-alpha (GO:0035457) | 2.46917613 |
| 98 | ribosomal small subunit biogenesis (GO:0042274) | 2.46870062 |
| 99 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.46559117 |
| 100 | regulation of protein heterodimerization activity (GO:0043497) | 2.46174049 |
| 101 | cytokine biosynthetic process (GO:0042089) | 2.45284284 |
| 102 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.44995015 |
| 103 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.44828646 |
| 104 | detection of molecule of bacterial origin (GO:0032490) | 2.44708595 |
| 105 | regulation of RIG-I signaling pathway (GO:0039535) | 2.44516280 |
| 106 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.44133465 |
| 107 | NIK/NF-kappaB signaling (GO:0038061) | 2.44026969 |
| 108 | defense response to virus (GO:0051607) | 2.43678611 |
| 109 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.43594755 |
| 110 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.43550062 |
| 111 | cytidine metabolic process (GO:0046087) | 2.42612171 |
| 112 | cytidine catabolic process (GO:0006216) | 2.42612171 |
| 113 | cytidine deamination (GO:0009972) | 2.42612171 |
| 114 | proteasome assembly (GO:0043248) | 2.42413800 |
| 115 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.42292336 |
| 116 | cell cycle G1/S phase transition (GO:0044843) | 2.42292336 |
| 117 | necroptotic process (GO:0070266) | 2.41809439 |
| 118 | response to protozoan (GO:0001562) | 2.41578166 |
| 119 | natural killer cell activation involved in immune response (GO:0002323) | 2.40616308 |
| 120 | monocyte chemotaxis (GO:0002548) | 2.40523480 |
| 121 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.40203451 |
| 122 | tryptophan metabolic process (GO:0006568) | 2.39397827 |
| 123 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.38565641 |
| 124 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.38199718 |
| 125 | lymphocyte mediated immunity (GO:0002449) | 2.38157565 |
| 126 | IMP biosynthetic process (GO:0006188) | 2.37997115 |
| 127 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.37733292 |
| 128 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.35829948 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.35527131 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.35527131 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.35527131 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.35527131 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.35527131 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.35527131 |
| 135 | positive regulation of interleukin-12 production (GO:0032735) | 2.34549041 |
| 136 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.34145869 |
| 137 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.33552759 |
| 138 | CENP-A containing nucleosome assembly (GO:0034080) | 2.33459145 |
| 139 | regulation of vitamin metabolic process (GO:0030656) | 2.32912757 |
| 140 | regulation of interleukin-1 beta production (GO:0032651) | 2.32784943 |
| 141 | positive regulation of cell cycle arrest (GO:0071158) | 2.32669816 |
| 142 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.32616386 |
| 143 | negative regulation of interleukin-1 production (GO:0032692) | 2.32583115 |
| 144 | negative regulation of mast cell activation (GO:0033004) | 2.30276106 |
| 145 | DNA strand elongation (GO:0022616) | 2.30066043 |
| 146 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.29616794 |
| 147 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.29480769 |
| 148 | eosinophil chemotaxis (GO:0048245) | 2.29473851 |
| 149 | actin nucleation (GO:0045010) | 2.29191088 |
| 150 | regulation of immunoglobulin secretion (GO:0051023) | 2.29132783 |
| 151 | DNA replication checkpoint (GO:0000076) | 2.28141896 |
| 152 | mitotic recombination (GO:0006312) | 2.27452954 |
| 153 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.26783689 |
| 154 | chromatin remodeling at centromere (GO:0031055) | 2.26742931 |
| 155 | IMP metabolic process (GO:0046040) | 2.25975302 |
| 156 | translational initiation (GO:0006413) | 2.25544278 |
| 157 | positive regulation of isotype switching (GO:0045830) | 2.25272177 |
| 158 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.24905789 |
| 159 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.24836824 |
| 160 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.24836824 |
| 161 | positive regulation of ligase activity (GO:0051351) | 2.23208366 |
| 162 | membrane raft organization (GO:0031579) | 2.22760463 |
| 163 | ribosome biogenesis (GO:0042254) | 2.22292637 |
| 164 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.20969358 |
| 165 | mitotic metaphase plate congression (GO:0007080) | 2.20483793 |
| 166 | translational elongation (GO:0006414) | 2.20408186 |
| 167 | positive regulation of interferon-beta production (GO:0032728) | 2.18971195 |
| 168 | DNA deamination (GO:0045006) | 2.18101673 |
| 169 | regulation of translation in response to stress (GO:0043555) | 2.18011429 |
| 170 | regulation of response to interferon-gamma (GO:0060330) | 2.17602084 |
| 171 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.17521455 |
| 172 | cullin deneddylation (GO:0010388) | 2.17497644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.24273936 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.68908793 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.54057800 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29278313 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.25321427 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.90402291 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.73754290 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.66936641 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66157961 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45988101 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.37115148 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31663137 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.27276692 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21935324 |
| 15 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.17705834 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.16382714 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.11207766 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.10193376 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06998007 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.02529863 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.02295011 |
| 22 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.00196484 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98652213 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.96158061 |
| 25 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.95495931 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.92936886 |
| 27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.88185863 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.85694534 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83171554 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.82827993 |
| 31 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82338986 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79298746 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77331754 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76935457 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76564216 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74122696 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74000724 |
| 38 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73862015 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73428218 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72411442 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72387491 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70247310 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.67896172 |
| 44 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66792285 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.63551756 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60550470 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59474479 |
| 48 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59249806 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58347681 |
| 50 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57579017 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55668821 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53663224 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53189985 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51544865 |
| 55 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.50924468 |
| 56 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.50125734 |
| 57 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47763186 |
| 58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46277873 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44310460 |
| 60 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.43094004 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.40219910 |
| 62 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39198094 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38780547 |
| 64 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.38461369 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38076946 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37912436 |
| 67 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.36877631 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.35450717 |
| 69 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.35088002 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34679145 |
| 71 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33933531 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32321540 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31485318 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.31008009 |
| 75 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29856623 |
| 76 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29424691 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29293211 |
| 78 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.26117884 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24779708 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23838317 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23444656 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22707135 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21894460 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21804161 |
| 85 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.21737629 |
| 86 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20749733 |
| 87 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20001967 |
| 88 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.18803221 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18313259 |
| 90 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.18284130 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17531461 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17347765 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16852985 |
| 94 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15290359 |
| 95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15013082 |
| 96 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14856092 |
| 97 | MYB_26560356_Chip-Seq_TH2_Human | 1.14100799 |
| 98 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11597297 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09447649 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08231386 |
| 101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08231386 |
| 102 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07749842 |
| 103 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.07578517 |
| 104 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05684874 |
| 105 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05049472 |
| 106 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04738796 |
| 107 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04643546 |
| 108 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03804088 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01171313 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00805709 |
| 111 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.00762455 |
| 112 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00603432 |
| 113 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00090982 |
| 114 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.98731996 |
| 115 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97294607 |
| 116 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96839081 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96620897 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93585753 |
| 119 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93076694 |
| 120 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92991547 |
| 121 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92909578 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92763247 |
| 123 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92671386 |
| 124 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92372257 |
| 125 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91782688 |
| 126 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91239808 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90872636 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90591397 |
| 129 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89863210 |
| 130 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89770363 |
| 131 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88405995 |
| 132 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87735676 |
| 133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84014611 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81808945 |
| 135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81808945 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79305189 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78706049 |
| 138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.78382383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 3.82823345 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.58890268 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.38451386 |
| 4 | MP0009785_altered_susceptibility_to | 2.94832741 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.88909316 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.76213553 |
| 7 | MP0003436_decreased_susceptibility_to | 2.72511221 |
| 8 | MP0003693_abnormal_embryo_hatching | 2.47215672 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.41574999 |
| 10 | MP0005275_abnormal_skin_tensile | 2.41177781 |
| 11 | MP0003724_increased_susceptibility_to | 2.31246941 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.25125348 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.22511619 |
| 14 | MP0000685_abnormal_immune_system | 2.11979575 |
| 15 | MP0005671_abnormal_response_to | 2.10150262 |
| 16 | MP0002419_abnormal_innate_immunity | 2.03749818 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.03589489 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.02569206 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.02170982 |
| 20 | MP0005025_abnormal_response_to | 2.00610000 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.92720022 |
| 22 | MP0002254_reproductive_system_inflammat | 1.88436537 |
| 23 | MP0003448_altered_tumor_morphology | 1.88238193 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.84211224 |
| 25 | MP0009840_abnormal_foam_cell | 1.83882927 |
| 26 | MP0003077_abnormal_cell_cycle | 1.80205110 |
| 27 | MP0002006_tumorigenesis | 1.80144824 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.79365869 |
| 29 | MP0002723_abnormal_immune_serum | 1.79308046 |
| 30 | MP0000858_altered_metastatic_potential | 1.75636468 |
| 31 | MP0005503_abnormal_tendon_morphology | 1.74888747 |
| 32 | MP0001800_abnormal_humoral_immune | 1.74817779 |
| 33 | MP0003195_calcinosis | 1.74729637 |
| 34 | MP0000343_altered_response_to | 1.74586691 |
| 35 | MP0001542_abnormal_bone_strength | 1.72954924 |
| 36 | MP0001819_abnormal_immune_cell | 1.72029196 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.70652318 |
| 38 | MP0003646_muscle_fatigue | 1.67845873 |
| 39 | MP0005023_abnormal_wound_healing | 1.67668769 |
| 40 | MP0002405_respiratory_system_inflammati | 1.64609952 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.61912352 |
| 42 | MP0001790_abnormal_immune_system | 1.61300435 |
| 43 | MP0005387_immune_system_phenotype | 1.61300435 |
| 44 | MP0001853_heart_inflammation | 1.59283493 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.59217495 |
| 46 | MP0003186_abnormal_redox_activity | 1.59168509 |
| 47 | MP0003111_abnormal_nucleus_morphology | 1.58360200 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.57983897 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.57834535 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.56421772 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.56421772 |
| 52 | MP0010307_abnormal_tumor_latency | 1.50503504 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.49979877 |
| 54 | MP0006082_CNS_inflammation | 1.44433160 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.42735738 |
| 56 | MP0008058_abnormal_DNA_repair | 1.40837645 |
| 57 | MP0005165_increased_susceptibility_to | 1.40811591 |
| 58 | MP0002398_abnormal_bone_marrow | 1.38376857 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.38285530 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.38063919 |
| 61 | MP0003075_altered_response_to | 1.37094926 |
| 62 | MP0000749_muscle_degeneration | 1.32342679 |
| 63 | MP0004947_skin_inflammation | 1.32018415 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.30894181 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.30810028 |
| 66 | MP0004084_abnormal_cardiac_muscle | 1.30491354 |
| 67 | MP0000716_abnormal_immune_system | 1.29601341 |
| 68 | MP0003091_abnormal_cell_migration | 1.28808144 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.28401092 |
| 70 | MP0003786_premature_aging | 1.27646404 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.27194439 |
| 72 | MP0008057_abnormal_DNA_replication | 1.26738247 |
| 73 | MP0003763_abnormal_thymus_physiology | 1.26416026 |
| 74 | MP0008932_abnormal_embryonic_tissue | 1.25619561 |
| 75 | MP0001958_emphysema | 1.21802430 |
| 76 | MP0003279_aneurysm | 1.19446821 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.18737789 |
| 78 | MP0005390_skeleton_phenotype | 1.17071962 |
| 79 | MP0002429_abnormal_blood_cell | 1.16019098 |
| 80 | MP0000490_abnormal_crypts_of | 1.15560157 |
| 81 | MP0005464_abnormal_platelet_physiology | 1.14282244 |
| 82 | MP0002722_abnormal_immune_system | 1.14031706 |
| 83 | MP0008004_abnormal_stomach_pH | 1.12622654 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 1.10826815 |
| 85 | MP0001243_abnormal_dermal_layer | 1.10752837 |
| 86 | MP0009278_abnormal_bone_marrow | 1.09364333 |
| 87 | MP0003303_peritoneal_inflammation | 1.07425380 |
| 88 | MP0002019_abnormal_tumor_incidence | 1.06475704 |
| 89 | MP0008260_abnormal_autophagy | 1.06455180 |
| 90 | MP0005330_cardiomyopathy | 1.06270110 |
| 91 | MP0005164_abnormal_response_to | 1.05298844 |
| 92 | MP0006054_spinal_hemorrhage | 1.04217278 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 1.04208394 |
| 94 | MP0005451_abnormal_body_composition | 1.03981705 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 1.02104755 |
| 96 | MP0000350_abnormal_cell_proliferation | 1.02039148 |
| 97 | MP0009764_decreased_sensitivity_to | 0.99920876 |
| 98 | MP0002933_joint_inflammation | 0.99858211 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.96649348 |
| 100 | MP0009763_increased_sensitivity_to | 0.94477241 |
| 101 | MP0000371_diluted_coat_color | 0.93935262 |
| 102 | MP0008469_abnormal_protein_level | 0.93474339 |
| 103 | MP0003828_pulmonary_edema | 0.93133195 |
| 104 | MP0005166_decreased_susceptibility_to | 0.92629568 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.91822491 |
| 106 | MP0003252_abnormal_bile_duct | 0.90787298 |
| 107 | MP0000750_abnormal_muscle_regeneration | 0.88492293 |
| 108 | MP0003941_abnormal_skin_development | 0.87896960 |
| 109 | MP0004272_abnormal_basement_membrane | 0.86939111 |
| 110 | MP0000627_abnormal_mammary_gland | 0.86850155 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.82735897 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.81937795 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.81280939 |
| 114 | MP0000313_abnormal_cell_death | 0.81107441 |
| 115 | MP0005266_abnormal_metabolism | 0.79926794 |
| 116 | MP0002972_abnormal_cardiac_muscle | 0.79761221 |
| 117 | MP0005621_abnormal_cell_physiology | 0.79698088 |
| 118 | MP0003718_maternal_effect | 0.78774223 |
| 119 | MP0001873_stomach_inflammation | 0.77803012 |
| 120 | MP0000703_abnormal_thymus_morphology | 0.77745178 |
| 121 | MP0004510_myositis | 0.77574197 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.75678901 |
| 123 | MP0003795_abnormal_bone_structure | 0.74632470 |
| 124 | MP0000249_abnormal_blood_vessel | 0.74630675 |
| 125 | MP0004883_abnormal_blood_vessel | 0.74479911 |
| 126 | MP0002060_abnormal_skin_morphology | 0.74454571 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.73718582 |
| 128 | MP0001730_embryonic_growth_arrest | 0.73474790 |
| 129 | MP0002295_abnormal_pulmonary_circulatio | 0.73282788 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.72756941 |
| 131 | MP0005623_abnormal_meninges_morphology | 0.72722199 |
| 132 | MP0002139_abnormal_hepatobiliary_system | 0.72199469 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.72055951 |
| 134 | MP0004036_abnormal_muscle_relaxation | 0.72003097 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.71380991 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.70963869 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.70946741 |
| 138 | MP0000767_abnormal_smooth_muscle | 0.70677807 |
| 139 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69448919 |
| 140 | MP0009765_abnormal_xenobiotic_induced | 0.68487348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.52243719 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.52243719 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.52243719 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.46996929 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.24915643 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.66169605 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.46621091 |
| 8 | Vertebral compression fractures (HP:0002953) | 3.36678639 |
| 9 | Birth length less than 3rd percentile (HP:0003561) | 3.34294563 |
| 10 | Myositis (HP:0100614) | 3.23987878 |
| 11 | Increased IgM level (HP:0003496) | 3.17892111 |
| 12 | Premature rupture of membranes (HP:0001788) | 3.13554462 |
| 13 | Reticulocytopenia (HP:0001896) | 3.11573837 |
| 14 | Thrombocytosis (HP:0001894) | 3.07054275 |
| 15 | Osteolytic defects of the hand bones (HP:0009699) | 3.01855965 |
| 16 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.01855965 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.93279972 |
| 18 | Orchitis (HP:0100796) | 2.87465206 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 2.82921615 |
| 20 | Abnormality of macrophages (HP:0004311) | 2.82757533 |
| 21 | Amniotic constriction ring (HP:0009775) | 2.78518469 |
| 22 | Abnormality of placental membranes (HP:0011409) | 2.78518469 |
| 23 | Cervical subluxation (HP:0003308) | 2.69836971 |
| 24 | Optic neuritis (HP:0100653) | 2.68403947 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 2.68403947 |
| 26 | Loss of speech (HP:0002371) | 2.66863891 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.63997468 |
| 28 | Agnosia (HP:0010524) | 2.62310875 |
| 29 | Poor head control (HP:0002421) | 2.57109248 |
| 30 | Chromsome breakage (HP:0040012) | 2.51984147 |
| 31 | Prostate neoplasm (HP:0100787) | 2.51955754 |
| 32 | Autoimmune hemolytic anemia (HP:0001890) | 2.44136006 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43956253 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.43499939 |
| 35 | Amyloidosis (HP:0011034) | 2.42713349 |
| 36 | Nausea (HP:0002018) | 2.42404823 |
| 37 | T lymphocytopenia (HP:0005403) | 2.41469989 |
| 38 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.39975980 |
| 39 | Myocardial infarction (HP:0001658) | 2.39658528 |
| 40 | Biconcave vertebral bodies (HP:0004586) | 2.38052561 |
| 41 | Breast hypoplasia (HP:0003187) | 2.35736360 |
| 42 | Parakeratosis (HP:0001036) | 2.35486764 |
| 43 | Peritonitis (HP:0002586) | 2.32689697 |
| 44 | Obstructive lung disease (HP:0006536) | 2.30745887 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30745887 |
| 46 | Type I transferrin isoform profile (HP:0003642) | 2.30399087 |
| 47 | Anorexia (HP:0002039) | 2.27331778 |
| 48 | Recurrent fungal infections (HP:0002841) | 2.24168600 |
| 49 | Generalized aminoaciduria (HP:0002909) | 2.23097644 |
| 50 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.22677411 |
| 51 | Stomatitis (HP:0010280) | 2.19010652 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15872502 |
| 53 | Aplastic anemia (HP:0001915) | 2.15451372 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.13844119 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.13347712 |
| 56 | Polyneuropathy (HP:0001271) | 2.10629499 |
| 57 | Abnormal protein glycosylation (HP:0012346) | 2.10290150 |
| 58 | Abnormal glycosylation (HP:0012345) | 2.10290150 |
| 59 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10290150 |
| 60 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10290150 |
| 61 | Vasculitis (HP:0002633) | 2.09277064 |
| 62 | Albinism (HP:0001022) | 2.08998187 |
| 63 | Keratoconjunctivitis (HP:0001096) | 2.08684149 |
| 64 | Rough bone trabeculation (HP:0100670) | 2.07167230 |
| 65 | Recurrent viral infections (HP:0004429) | 2.07032615 |
| 66 | Neoplasm of head and neck (HP:0012288) | 2.06220356 |
| 67 | Esophageal neoplasm (HP:0100751) | 2.06220356 |
| 68 | Dysostosis multiplex (HP:0000943) | 2.05861421 |
| 69 | Hemoptysis (HP:0002105) | 2.05062215 |
| 70 | Trismus (HP:0000211) | 2.04448712 |
| 71 | Cellulitis (HP:0100658) | 2.02949329 |
| 72 | Recurrent skin infections (HP:0001581) | 2.02261518 |
| 73 | Increased CSF lactate (HP:0002490) | 2.02198737 |
| 74 | Ankle contracture (HP:0006466) | 2.00008102 |
| 75 | Cortical dysplasia (HP:0002539) | 1.99116366 |
| 76 | Syringomyelia (HP:0003396) | 1.97074496 |
| 77 | Spinal cord lesions (HP:0100561) | 1.97074496 |
| 78 | Petechiae (HP:0000967) | 1.96789333 |
| 79 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94588007 |
| 80 | Amaurosis fugax (HP:0100576) | 1.93709356 |
| 81 | Abnormality of the calcaneus (HP:0008364) | 1.92129554 |
| 82 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90965773 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90965773 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90965773 |
| 85 | Mitochondrial inheritance (HP:0001427) | 1.89156059 |
| 86 | Leukocytosis (HP:0001974) | 1.88962217 |
| 87 | Abnormality of the prostate (HP:0008775) | 1.88883739 |
| 88 | Osteomyelitis (HP:0002754) | 1.88877987 |
| 89 | Hepatocellular necrosis (HP:0001404) | 1.87826320 |
| 90 | Basal ganglia calcification (HP:0002135) | 1.87538484 |
| 91 | Gangrene (HP:0100758) | 1.87052352 |
| 92 | Gingivitis (HP:0000230) | 1.84656858 |
| 93 | Delayed gross motor development (HP:0002194) | 1.83864646 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 1.83130633 |
| 95 | Distal lower limb muscle weakness (HP:0009053) | 1.83019033 |
| 96 | Disinhibition (HP:0000734) | 1.82808634 |
| 97 | Abnormality of the pons (HP:0007361) | 1.82622769 |
| 98 | Abnormality of T cells (HP:0002843) | 1.82618433 |
| 99 | Hepatosplenomegaly (HP:0001433) | 1.80804825 |
| 100 | Muscle fiber atrophy (HP:0100295) | 1.80614292 |
| 101 | Intrahepatic cholestasis (HP:0001406) | 1.80600281 |
| 102 | Degeneration of anterior horn cells (HP:0002398) | 1.80435660 |
| 103 | Abnormality of the anterior horn cell (HP:0006802) | 1.80435660 |
| 104 | Abnormal trabecular bone morphology (HP:0100671) | 1.79392400 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 1.79391433 |
| 106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78823224 |
| 107 | Pallor (HP:0000980) | 1.78782591 |
| 108 | Increased serum ferritin (HP:0003281) | 1.78742746 |
| 109 | Urticaria (HP:0001025) | 1.78494221 |
| 110 | Pulmonary infiltrates (HP:0002113) | 1.78319867 |
| 111 | Abnormality of T cell physiology (HP:0011840) | 1.78208873 |
| 112 | Meckel diverticulum (HP:0002245) | 1.77919234 |
| 113 | Pustule (HP:0200039) | 1.77733334 |
| 114 | Skin ulcer (HP:0200042) | 1.77290889 |
| 115 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.77265336 |
| 116 | Abnormality of chromosome stability (HP:0003220) | 1.77007510 |
| 117 | IgA deficiency (HP:0002720) | 1.76707160 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.75630073 |
| 119 | Gastrointestinal infarctions (HP:0005244) | 1.75603477 |
| 120 | Decreased subcutaneous fat (HP:0001002) | 1.75190381 |
| 121 | Myelodysplasia (HP:0002863) | 1.75138325 |
| 122 | Hepatic necrosis (HP:0002605) | 1.75019316 |
| 123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.74080480 |
| 124 | Pulmonary fibrosis (HP:0002206) | 1.73971544 |
| 125 | Recurrent pneumonia (HP:0006532) | 1.73718654 |
| 126 | Nuclear cataract (HP:0100018) | 1.73414279 |
| 127 | Eosinophilia (HP:0001880) | 1.73384535 |
| 128 | IgG deficiency (HP:0004315) | 1.73106947 |
| 129 | Carpal bone hypoplasia (HP:0001498) | 1.72321323 |
| 130 | Abnormality of the preputium (HP:0100587) | 1.72049515 |
| 131 | Facial diplegia (HP:0001349) | 1.71501116 |
| 132 | Hematochezia (HP:0002573) | 1.70948723 |
| 133 | Type 2 muscle fiber atrophy (HP:0003554) | 1.70623139 |
| 134 | 11 pairs of ribs (HP:0000878) | 1.69786270 |
| 135 | Increased connective tissue (HP:0009025) | 1.69684585 |
| 136 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.69486731 |
| 137 | Keratoconjunctivitis sicca (HP:0001097) | 1.68837308 |
| 138 | Wormian bones (HP:0002645) | 1.68328725 |
| 139 | Spondylolisthesis (HP:0003302) | 1.68018709 |
| 140 | Atrophic scars (HP:0001075) | 1.66811420 |
| 141 | Granulocytopenia (HP:0001913) | 1.66577944 |
| 142 | Absent thumb (HP:0009777) | 1.66298783 |
| 143 | Reduced antithrombin III activity (HP:0001976) | 1.66298220 |
| 144 | Entropion (HP:0000621) | 1.66071173 |
| 145 | Selective tooth agenesis (HP:0001592) | 1.64913535 |
| 146 | Tetraparesis (HP:0002273) | 1.64729819 |
| 147 | Palpitations (HP:0001962) | 1.64724821 |
| 148 | Abnormality of T cell number (HP:0011839) | 1.64431973 |
| 149 | Short nail (HP:0001799) | 1.64398892 |
| 150 | Abnormality of the pericardium (HP:0001697) | 1.64348135 |
| 151 | Wrist flexion contracture (HP:0001239) | 1.64336630 |
| 152 | Nemaline bodies (HP:0003798) | 1.64199317 |
| 153 | Fused cervical vertebrae (HP:0002949) | 1.64117438 |
| 154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.63926073 |
| 155 | Mucopolysacchariduria (HP:0008155) | 1.63926073 |
| 156 | Porencephaly (HP:0002132) | 1.63874104 |
| 157 | Follicular hyperkeratosis (HP:0007502) | 1.62740120 |
| 158 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.62708093 |
| 159 | Abnormality of alanine metabolism (HP:0010916) | 1.62708093 |
| 160 | Hyperalaninemia (HP:0003348) | 1.62708093 |
| 161 | Acute encephalopathy (HP:0006846) | 1.61758421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.36580637 |
| 2 | MAP3K14 | 3.01025361 |
| 3 | PIM2 | 2.99267183 |
| 4 | ACVR1B | 2.72127265 |
| 5 | EIF2AK1 | 2.67956836 |
| 6 | EIF2AK3 | 2.56839312 |
| 7 | BUB1 | 2.41358789 |
| 8 | WEE1 | 2.26563775 |
| 9 | TESK1 | 2.23306065 |
| 10 | MST4 | 2.23113274 |
| 11 | PBK | 2.15946960 |
| 12 | MAPKAPK3 | 2.15532631 |
| 13 | TGFBR2 | 2.14992313 |
| 14 | GRK7 | 2.08488999 |
| 15 | ADRBK2 | 2.06162033 |
| 16 | TESK2 | 1.98645162 |
| 17 | TXK | 1.91329198 |
| 18 | BLK | 1.84596749 |
| 19 | JAK3 | 1.69246353 |
| 20 | ZAP70 | 1.65459103 |
| 21 | FRK | 1.64784992 |
| 22 | MUSK | 1.64090822 |
| 23 | TIE1 | 1.63001069 |
| 24 | IKBKB | 1.62514252 |
| 25 | MAP4K2 | 1.60160146 |
| 26 | TBK1 | 1.59934614 |
| 27 | IRAK4 | 1.59233373 |
| 28 | RPS6KA4 | 1.52951989 |
| 29 | ZAK | 1.47276747 |
| 30 | TYK2 | 1.46157257 |
| 31 | TRPM7 | 1.46051805 |
| 32 | PIM1 | 1.44622492 |
| 33 | TEC | 1.43540841 |
| 34 | LIMK1 | 1.35887535 |
| 35 | TGFBR1 | 1.35749939 |
| 36 | EPHA2 | 1.32719288 |
| 37 | EIF2AK2 | 1.31612454 |
| 38 | MATK | 1.30456370 |
| 39 | KDR | 1.25549781 |
| 40 | RIPK4 | 1.25479939 |
| 41 | KIT | 1.24385087 |
| 42 | MST1R | 1.23164283 |
| 43 | LRRK2 | 1.22935067 |
| 44 | NEK9 | 1.22318682 |
| 45 | VRK2 | 1.19876946 |
| 46 | OXSR1 | 1.19086096 |
| 47 | STK10 | 1.18872419 |
| 48 | CDK19 | 1.15259687 |
| 49 | MOS | 1.15081606 |
| 50 | MAP4K1 | 1.13782630 |
| 51 | CDC7 | 1.11550106 |
| 52 | ERBB3 | 1.09249225 |
| 53 | ARAF | 1.07087545 |
| 54 | ERBB4 | 1.04921379 |
| 55 | BRSK2 | 1.04499091 |
| 56 | IKBKE | 1.03455293 |
| 57 | STK16 | 1.02622503 |
| 58 | MAP3K3 | 1.02334740 |
| 59 | MAP3K12 | 1.02325500 |
| 60 | NUAK1 | 1.00414453 |
| 61 | TTN | 1.00152996 |
| 62 | PLK1 | 0.99763166 |
| 63 | PLK4 | 0.99563229 |
| 64 | IRAK3 | 0.98440226 |
| 65 | PDK2 | 0.97707098 |
| 66 | TAOK2 | 0.96897340 |
| 67 | NEK1 | 0.95594564 |
| 68 | AURKB | 0.91351170 |
| 69 | ADRBK1 | 0.90499601 |
| 70 | MAP2K3 | 0.90215123 |
| 71 | TSSK6 | 0.87020673 |
| 72 | MKNK1 | 0.84278790 |
| 73 | MYLK | 0.83898466 |
| 74 | PAK4 | 0.83793930 |
| 75 | FGR | 0.83589300 |
| 76 | ABL2 | 0.83441215 |
| 77 | RPS6KB2 | 0.82705839 |
| 78 | BMX | 0.80865591 |
| 79 | CHUK | 0.78146878 |
| 80 | PLK3 | 0.77917840 |
| 81 | GRK1 | 0.75091867 |
| 82 | CLK1 | 0.74613452 |
| 83 | TAOK3 | 0.73216267 |
| 84 | SYK | 0.72803546 |
| 85 | CSK | 0.71056167 |
| 86 | BTK | 0.70944746 |
| 87 | MAP3K8 | 0.68984425 |
| 88 | VRK1 | 0.66327736 |
| 89 | STK4 | 0.65659378 |
| 90 | LYN | 0.64872392 |
| 91 | ATR | 0.64850071 |
| 92 | FLT3 | 0.64098827 |
| 93 | JAK1 | 0.63650806 |
| 94 | TTK | 0.61442917 |
| 95 | MAP3K5 | 0.61070404 |
| 96 | MELK | 0.61069909 |
| 97 | LCK | 0.60795071 |
| 98 | TLK1 | 0.57502515 |
| 99 | CAMKK2 | 0.57135698 |
| 100 | TRIM28 | 0.56236953 |
| 101 | STK38L | 0.56156316 |
| 102 | PAK1 | 0.55267768 |
| 103 | BMPR1B | 0.54421655 |
| 104 | PTK2B | 0.53502985 |
| 105 | SIK3 | 0.52723213 |
| 106 | BMPR2 | 0.52680271 |
| 107 | CDK7 | 0.52605868 |
| 108 | NEK2 | 0.51764739 |
| 109 | MET | 0.51737148 |
| 110 | HCK | 0.51215167 |
| 111 | YES1 | 0.50688508 |
| 112 | MARK3 | 0.49655372 |
| 113 | AURKA | 0.47585660 |
| 114 | MAPKAPK2 | 0.47185063 |
| 115 | ITK | 0.46113989 |
| 116 | PDK4 | 0.46043490 |
| 117 | PDK3 | 0.46043490 |
| 118 | CDC42BPA | 0.45353941 |
| 119 | MAP3K11 | 0.45310230 |
| 120 | FER | 0.45303825 |
| 121 | STK24 | 0.45141395 |
| 122 | BRAF | 0.44828759 |
| 123 | ABL1 | 0.44622805 |
| 124 | SRPK1 | 0.44483243 |
| 125 | OBSCN | 0.43580737 |
| 126 | PLK2 | 0.41254014 |
| 127 | DAPK3 | 0.41156183 |
| 128 | PIK3CG | 0.41022295 |
| 129 | DDR2 | 0.40914979 |
| 130 | CSNK2A1 | 0.40837156 |
| 131 | PRKCD | 0.39722494 |
| 132 | CCNB1 | 0.38779438 |
| 133 | STK3 | 0.38488456 |
| 134 | ROCK1 | 0.36163751 |
| 135 | IRAK1 | 0.33558076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.71792740 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.69908054 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.62549402 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.41920756 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.33909530 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.28761604 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.16065473 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.15993555 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.15759174 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02318888 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.00392266 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.97764905 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76879314 |
| 14 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.70324618 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.69338568 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.67444281 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.60185969 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59023064 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.58157267 |
| 20 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.57186072 |
| 21 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.56586612 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.54510244 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.53494585 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53002555 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52492001 |
| 26 | RNA transport_Homo sapiens_hsa03013 | 1.51997596 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50983301 |
| 28 | Cell cycle_Homo sapiens_hsa04110 | 1.46873198 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46589757 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.46053005 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40763538 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40601313 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35363728 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.32334501 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31615304 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.31420142 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.30778870 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.29728421 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.29311992 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26572952 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24702007 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.22012060 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 1.21792262 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20709738 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.20441288 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19018226 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18286324 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.14519037 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.13582840 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10014824 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09092105 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08432878 |
| 53 | Asthma_Homo sapiens_hsa05310 | 1.06069138 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05288843 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.02927928 |
| 56 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.02499255 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 1.02063681 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01159292 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 1.00484068 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.99655399 |
| 61 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.98423627 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95569783 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91701754 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87044982 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83612999 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83396554 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81444433 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81086147 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.81008606 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79475553 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77075872 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76582652 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76580885 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72611173 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71384785 |
| 76 | Purine metabolism_Homo sapiens_hsa00230 | 0.70929569 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70855119 |
| 78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70318517 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69948880 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69809049 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68177768 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66946299 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66307213 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65362980 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60325226 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59867915 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.57354580 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.57048635 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56964555 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55462946 |
| 91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55181962 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55170473 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.54641641 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53995913 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52260424 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51098196 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50644524 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50382566 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48873790 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47189910 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46074546 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44282055 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44269307 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44192003 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.44177359 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.44136073 |
| 107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42383652 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41990863 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.41573176 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41404335 |
| 111 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40958248 |
| 112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40316141 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39606356 |
| 114 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.39133321 |
| 115 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39083428 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38877588 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.38332858 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37880012 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37359636 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37258105 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36917795 |
| 122 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36611306 |
| 123 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35733966 |
| 124 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34931846 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.34097252 |
| 126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33921925 |
| 127 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33856087 |
| 128 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31594606 |

